近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Mavrou, A, Brakspear, K, Hamdollah-Zadeh, M, Damodaran, G, Babaei-Jadidi, R, Oxley, J, Gillatt, DA, Ladomery, MR, Harper, SJ, Bates, DO & Oltean, S, 2015, ‘Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer’. Oncogene. Zadeh, MAH, Amin, EM, Hoareau-Aveilla, C, Domingo, E, Symonds, KE, Ye, X, Heesom, KJ, Salmon, A, D'Silva, O, Betteridge, KB, Williams, AC, Kerr, DJ, Salmon, AHJ, Oltean, S, Midgley, RS, Ladomery, MR, Harper, SJ, Varey, AHR & Bates, DO, 2015, ‘Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance’. Molecular Oncology, vol 9., pp. 167-78 Urban, BC, Collard, TJ, Eagle, CJ, Southern, SL, Greenhough, A, Hamdollah-Zadeh, M, Ghosh, A, Poulsom, R, Paraskeva, C, Silver, A & Williams, AC, 2015, ‘BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling’. Gut. Bates, DO, Mavrou, A, Qiu, Y, Carter, JG, Hamdollah-Zadeh, M, Barratt, S, Gammons, MV, Millar, AB, Salmon, AHJ, Oltean, S & Harper, SJ, 2013, ‘Detection of VEGF-Axxxb Isoforms in Human Tissues’. PloS one, vol 8., pp. e68399 Oltean, S, Gammons, M, Hulse, R, Hamdollah-Zadeh, M, Mavrou, A, Donaldson, L, Salmon, AH, Harper, SJ, Ladomery, MR & Bates, DO, 2012, ‘SRPK1 inhibition in vivo: Modulation of VEGF splicing and potential treatment for multiple diseases’. Biochemical Society transactions, vol 40., pp. 831-835 Amin, E, Oltean, S, Hua, J, Gammons, M, Hamdollah-Zadeh, A, Welsh, G, Cheung, M, Ni, L, Kase, S, Rennel, E, Symonds, K, Nowak, D, Royer-Pokora, B, Saleem, M, Hagiwara, M, Schumacher, V, Harper, S, Hinton, D, Bates, D & Ladomery, M, 2011, ‘WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing’. Cancer Cell, vol 20., pp. 768 - 780 Hamdollah-Zadeh, A, Glass, C, Magnussen, A, Hancox, J & Bates, D, 2008, ‘VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6’. Mircrocirculation, vol 15., pp. 605 - 614